OSX2:F:F-Ossiam Lux - Ossiam US Minimum Variance NR (EUR)

ETF | Others |

Last Closing

USD 283.6

Change

+2.25 (+0.80)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.47 (+1.77%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+1.16 (+2.34%)

USD 108.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

+6.50 (+1.21%)

USD 93.32B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+1.00 (+1.84%)

USD 86.92B
SXRZ:F iShares VII PLC - iShares Nikk..

+6.50 (+2.82%)

USD 53.24B
VUAA:F Vanguard S&P 500 UCITS Acc

+1.11 (+1.16%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.36 (+2.43%)

USD 51.19B
XJSE:F Xtrackers II - Japan Governmen..

-0.11 (-1.34%)

USD 41.09B
0ZC:F Zscaler Inc

+0.60 (+0.40%)

USD 37.92B

ETFs Containing OSX2:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.96% 78% C+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.96% 75% C 63% D
Trailing 12 Months  
Capital Gain 14.33% 63% D 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.33% 59% D- 57% F
Trailing 5 Years  
Capital Gain 36.25% 57% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 36.25% 57% F 49% F
Average Annual (5 Year Horizon)  
Capital Gain 6.77% 64% D 64% D
Dividend Return 6.77% 61% D- 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.89% 66% D+ 88% B+
Risk Adjusted Return 68.40% 81% B- 84% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike